Bronchial hyperresponsiveness and airway wall remodelling induced by exposure to allergen for 9 weeks.
Prolonged exposure to allergen has been proposed to be important for the development of bronchial hyperresponsiveness and airway remodelling in asthma. The present study was designed to examine the effect of chronic allergen exposure on bronchial responsiveness, eosinophil infiltration, and airway remodelling. We sensitized brown Norway rats with the occupational allergen trimellitic anhydride (TMA) and exposed the animals to TMA conjugated to rat serum albumin (TMA-RSA) on 5 consecutive days each week for 9 weeks, starting 4 weeks after sensitization. IgE and IgG anti-TMA antibodies in serum and bronchial responsiveness to acetylcholine were evaluated before and at weeks 3, 6, and 9 of allergen exposure. Thickness of the airway wall, airway luminal narrowing, and the number of goblet cells and eosinophils in the airway wall were evaluated with an image analysis system in lungs resected after the last assessment of bronchial responsiveness, at the end of the 9-week allergen exposure. All rats developed IgE and IgG anti-TMA antibodies after sensitization. The levels of antibodies increased with allergen exposure until week 6, and then declined. Bronchial hyperresponsiveness to acetylcholine was induced in allergen-exposed rats without ongoing airway eosinophilia. Bronchial hyperresponsiveness induced by chronic allergen exposure via inhalation was accompanied by significantly increased thickness of smooth muscle and airway narrowing in the small airways, and goblet cell hyperplasia in the large airways. We conclude that chronic exposure to allergen can induce bronchial hyperresponsiveness and airway wall remodelling. Airway wall remodelling may contribute to bronchial hyperresponsiveness.
Cui
Z H
ZH
Department of Respiratory Medicine and Allergology, Göteborg University, Sweden.
Skoogh
B E
BE
Pullerits
T
T
Lötvall
J
J
D000403:Airway Resistance; D000485:Allergens / Q000009:adverse effects*; D000818:Animals; D000906:Antibodies / Q000097:blood; D001980:Bronchi / Q000473:pathology*; D016535:Bronchial Hyperreactivity / Q000097:blood / Q000276:immunology* / Q000473:pathology; D004781:Environmental Exposure / Q000009:adverse effects*; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D008297:Male; D009130:Muscle, Smooth / Q000473:pathology; D010796:Phthalic Anhydrides / Q000276:immunology; D051381:Rats; D011914:Rats, Inbred BN; D012137:Respiratory System / Q000473:pathology; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors
D000485:Allergens; D000906:Antibodies; D007074:Immunoglobulin G; D010796:Phthalic Anhydrides; D007073:Immunoglobulin E; C015559:trimellitic anhydride